Literature DB >> 18286441

Advances in approaches to the cranial base: minimizing morbidity.

Michael R Shohet1, Kurt Laedrach, Raphael Guzman, Joram Raveh.   

Abstract

The most innovative and meaningful recent advances regarding surgery of the cranial base involve the ability to perform a complete resection followed by a water- and airtight reconstruction while minimizing facial incisions and morbidity. Perhaps the first step in this direction took place when the subcranial/subfrontal approach was introduced for anterior skull base surgery. Originally developed by Raveh in 1978 for the management of severe skull base injuries, these approaches were later adapted for the treatment of congenital anomalies prior to their utilization for resection of anterior skull base tumors. The endoscopic approaches are quite practical with promising long-term efficacy for the treatment of most benign, infectious, and inflammatory disorders. The minimal recovery time, functional outcomes, and obvious aesthetic advantages are only tempered by the lack of long-term data regarding the efficacy of these approaches in the treatment of malignancies.

Entities:  

Mesh:

Year:  2008        PMID: 18286441     DOI: 10.1055/s-2008-1037454

Source DB:  PubMed          Journal:  Facial Plast Surg        ISSN: 0736-6825            Impact factor:   1.446


  3 in total

1.  Perioperative outcomes in patients undergoing the transglabellar/subcranial approach to the anterior skull base.

Authors:  Jon-Paul Pepper; P Daniel Ward; Erin M Lin; Stephen E Sullivan; Sarah L Hecht; Lawrence J Marentette
Journal:  Skull Base       Date:  2011-07

2.  Subcranial approach in pediatric craniofacial surgery.

Authors:  Jorge Ciechomski; Ruben Aufgang; Lucrecia Villanueva; Victoria Demarchi
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2010-12

3.  A simple classification of cranial-nasal-orbital communicating tumors that facilitate choice of surgical approaches: analysis of a series of 32 cases.

Authors:  Yue-Fei Deng; Bing-Xi Lei; Mei-Guang Zheng; Yi-Qing Zheng; Wei-Liang Chen; Yu-Qing Lan
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-26       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.